PFE Jan 2025 40.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 12.05 |
| Open | 12.05 |
| Bid | 11.35 |
| Ask | 11.85 |
| Strike | 40.00 |
| Expiry date | 2025-01-17 |
| Day's range | 12.05 - 12.05 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.79k |
PR NewswireAstellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will share new research from across its innovative portfolio of approved and investigational cancer therapies during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting from May 31 - June 4. A total of 16 abstracts will be presented, including new data from pivotal trials supporting ongoing regulatory reviews. The volume of data being presented by Astellas reinforces its commitment to changing the cou
ZacksThe Zacks Analyst Blog Highlights Amazon, Visa, Pfizer, Martin Marietta Materials and Zimmer Biomet
Amazon, Visa, Pfizer, Martin Marietta Materials and Zimmer Biomet are included in this Analyst Blog.
Simply Wall St.Pfizer Inc. Just Beat EPS By 61%: Here's What Analysts Think Will Happen Next
Pfizer Inc. ( NYSE:PFE ) just released its first-quarter report and things are looking bullish. It was overall a...
© 2024 Yahoo. All rights reserved.